These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 15737511

  • 1. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
    Manno G, Cruciani M, Romano L, Scapolan S, Mentasti M, Lorini R, Minicucci L.
    Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
    [Abstract] [Full Text] [Related]

  • 2. [Pseudomonas aeruginosa: antimicrobial resistance in clinical isolates. Castellón 2004-2008].
    Pardo Serrano FJ, Tirado Balaguer MD, García Zúñiga ED, Granados Ortega J, Campos Aznar A, Moreno Muñoz R.
    Rev Esp Quimioter; 2010 Mar; 23(1):20-6. PubMed ID: 20232020
    [Abstract] [Full Text] [Related]

  • 3. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.
    Perry JD, Laine L, Hughes S, Nicholson A, Galloway A, Gould FK.
    J Antimicrob Chemother; 2008 May; 61(5):1057-61. PubMed ID: 18316821
    [Abstract] [Full Text] [Related]

  • 4. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M, Carbonnelle S, Avrain L, Mesaros N, Pirnay JP, Bilocq F, De Vos D, Simon A, Piérard D, Jacobs F, Dediste A, Tulkens PM, Van Bambeke F, Glupczynski Y.
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
    Raja NS, Singh NN.
    J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005.
    Babay HA.
    Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646
    [Abstract] [Full Text] [Related]

  • 7. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
    López-Dupla M, Martínez JA, Vidal F, Almela M, Soriano A, Marco F, López J, Olona M, Mensa J.
    Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049
    [Abstract] [Full Text] [Related]

  • 8. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms.
    Bosso JA, Mauldin PD, Steed LL.
    Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687
    [Abstract] [Full Text] [Related]

  • 9. Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
    Wu YL, Scott EM, Po AL, Tariq VN.
    APMIS; 1999 Jun; 107(6):585-92. PubMed ID: 10379686
    [Abstract] [Full Text] [Related]

  • 10. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
    Minchella A, Molinari L, Alonso S, Bouziges N, Sotto A, Lavigne JP.
    Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E, Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient.
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [Abstract] [Full Text] [Related]

  • 12. Characterization by phenotypic and genotypic methods of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Li Y, Zhang X, Wang C, Hu Y, Niu X, Pei D, He Z, Bi Y.
    Mol Med Rep; 2015 Jan; 11(1):494-8. PubMed ID: 25323940
    [Abstract] [Full Text] [Related]

  • 13. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
    Ciofu O, Giwercman B, Pedersen SS, Høiby N.
    APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
    [Abstract] [Full Text] [Related]

  • 14. High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic.
    Vosahlikova S, Drevinek P, Cinek O, Pohunek P, Maixnerova M, Urbaskova P, van den Reijden TJ, Dijkshoorn L, Nemec A.
    Res Microbiol; 2007 May; 158(4):324-9. PubMed ID: 17448645
    [Abstract] [Full Text] [Related]

  • 15. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
    Gillham MI, Sundaram S, Laughton CR, Haworth CS, Bilton D, Foweraker JE.
    J Antimicrob Chemother; 2009 Apr; 63(4):728-32. PubMed ID: 19193658
    [Abstract] [Full Text] [Related]

  • 16. Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004.
    Messadi AA, Lamia T, Kamel B, Salima O, Monia M, Saida BR.
    Burns; 2008 Dec; 34(8):1098-102. PubMed ID: 18619737
    [Abstract] [Full Text] [Related]

  • 17. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
    Coban AY, Ciftci A, Onuk EE, Erturan Z, Tanriverdi Cayci Y, Durupinar B.
    Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
    [Abstract] [Full Text] [Related]

  • 18. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Møller NE, Høiby N.
    Scand J Infect Dis Suppl; 1981 Oct; 29():87-91. PubMed ID: 6458884
    [Abstract] [Full Text] [Related]

  • 19. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR, Pressler T, Høiby N.
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [Abstract] [Full Text] [Related]

  • 20. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H.
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.